We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
56 hedge funds and large institutions have $62.9M invested in Larimar Therapeutics in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
2,133% more call options, than puts
Call options by funds: $67K | Put options by funds: $3K
34% more capital invested
Capital invested by funds: $47M → $62.9M (+$15.9M)
0.07% more ownership
Funds ownership: 4.05% → 4.12% (+0.07%)
10% less funds holding
Funds holding: 62 → 56 (-6)
16% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 19
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Holders
56
Holders Change
-6
Holders Change %
-9.68%
% of All Funds
1.27%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
16
Reduced
19
Closed
9
Calls
$67K
Puts
$3K
Net Calls
+$64K
Net Calls Change
+$24K
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$2.09M |
| 2 |
RA
Royce & Associates
New York
|
+$811K |
| 3 |
NC
Nexthera Capital
New York
|
+$644K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$390K |
| 5 |
Bank of New York Mellon
New York
|
+$191K |
